Skip to content

Research at St Andrews

The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems

Research output: Contribution to journalArticlepeer-review

Author(s)

Min Wu, Hermann B. Frieboes, Mark A. J. Chaplain, Steven R. McDougall, Vittorio Cristini, John S. Lowengrub

School/Research organisations

Abstract

Vascularized tumor growth is characterized by both abnormal interstitial fluid flow and the associated interstitial fluid pressure (IFP). Here, we study the effect that these conditions have on the transport of therapeutic agents during chemotherapy. We apply our recently developed vascular tumor growth model which couples a continuous growth component with a discrete angiogenesis model to show that hypertensive IFP is a physical barrier that may hinder vascular extravasation of agents through transvascular fluid flux convection, which drives the agents away from the tumor. This result is consistent with previous work using simpler models without blood flow or lymphatic drainage. We consider the vascular/interstitial/lymphatic fluid dynamics to show that tumors with larger lymphatic resistance increase the agent concentration more rapidly while also experiencing faster washout. In contrast, tumors with smaller lymphatic resistance accumulate less agents but are able to retain them for a longer time. The agent availability (area-under-the curve, or AUC) increases for less permeable agents as lymphatic resistance increases, and correspondingly decreases for more permeable agents. We also investigate the effect of vascular pathologies on agent transport. We show that elevated vascular hydraulic conductivity contributes to the highest AUC when the agent is less permeable, but to lower AUC when the agent is more permeable. We find that elevated interstitial hydraulic conductivity contributes to low AUC in general regardless of the transvascular agent transport capability. We also couple the agent transport with the tumor dynamics to simulate chemotherapy with the same vascularized tumor under different vascular pathologies. We show that tumors with an elevated interstitial hydraulic conductivity alone require the strongest dosage to shrink. We further show that tumors with elevated vascular hydraulic conductivity are more hypoxic during therapy and that the response slows down as the tumor shrinks due to the heterogeneity and low concentration of agents in the tumor interior compared with the cases where other pathological effects may combine to flatten the IFP and thus reduce the heterogeneity. We conclude that dual normalizations of the micronevironment ? both the vasculature and the interstitium ? are needed to maximize the effects of chemotherapy, while normalization of only one of these may be insufficient to overcome the physical resistance and may thus lead to sub-optimal outcomes.
Close

Details

Original languageEnglish
Pages (from-to)194-207
Number of pages14
JournalJournal of Theoretical Biology
Volume355
DOIs
Publication statusPublished - 21 Aug 2014

    Research areas

  • Chemotherapy, Cancer simulation, Tumor vasculature, Tumor lymphatics, Interstitial fluid pressure

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. A novel 3D atomistic-continuum cancer invasion model: in silico simulations of an in vitro organotypic invasion assay

    Franssen, L. C., Sfakianakis, N. & Chaplain, M. A. J., 7 Aug 2021, In: Journal of Theoretical Biology. 522, 14 p., 110677.

    Research output: Contribution to journalArticlepeer-review

  2. Mechanical models of pattern and form in biological tissues: the role of stress-strain constitutive equations

    Villa, C., Chaplain, M. A. J., Gerisch, A. & Lorenzi, T., 26 May 2021, In: Bulletin of Mathematical Biology. 83, 38 p., 80.

    Research output: Contribution to journalArticlepeer-review

  3. Development of a coupled simulation toolkit for computational radiation biology based on Geant4 and CompuCell3D

    Liu, R., Higley, K., Swat, M., Chaplain, M. A. J., Powathil, G. & Glazier, J., 10 Feb 2021, In: Physics in Medicine and Biology. 66, 4, 20 p., 045026.

    Research output: Contribution to journalArticlepeer-review

  4. Modeling the emergence of phenotypic heterogeneity in vascularized tumors

    Villa, C., Chaplain, M. A. & Lorenzi, T., 2021, In: SIAM Journal on Applied Mathematics. 81, 2, p. 434-453 20 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Journal of Theoretical Biology (Journal)

    Mark Andrew Joseph Chaplain (Editor)

    10 Apr 2017 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. A novel 3D atomistic-continuum cancer invasion model: in silico simulations of an in vitro organotypic invasion assay

    Franssen, L. C., Sfakianakis, N. & Chaplain, M. A. J., 7 Aug 2021, In: Journal of Theoretical Biology. 522, 14 p., 110677.

    Research output: Contribution to journalArticlepeer-review

  2. Consistency and identifiability of the polymorphism-aware phylogenetic models

    Borges, R. & Kosiol, C., 7 Feb 2020, In: Journal of Theoretical Biology. 486, p. 1-6 6 p., 110074.

    Research output: Contribution to journalArticlepeer-review

  3. Modelling the effects of environmental heterogeneity within the lung on the tuberculosis life-cycle

    Pitcher, M. J., Bowness, R., Dobson, S. A., Eftimie, R. & Gillespie, S. H., 7 Dec 2020, In: Journal of Theoretical Biology. 506, 18 p., 110381.

    Research output: Contribution to journalArticlepeer-review

  4. A theory for investment across defences triggered at different stages of a predator-prey encounter

    Wang, L., Ruxton, G. D., Cornell, S. J., Speed, M. P. & Broom, M., 21 Jul 2019, In: Journal of Theoretical Biology. 473, p. 9-19 11 p.

    Research output: Contribution to journalArticlepeer-review

ID: 206440313

Top